Form 4 filed by Kumar Neil
Kumar Neil filed this Form 4 on BBIO (BridgeBio Pharma, Inc.) with 6 transaction rows and 2 holding rows, accepted by EDGAR 2026-11-20 21:33:18 UTC.
- Accession
- 0001743881-26-000045
- Filer
- CIK 1742485
- Filed
- 2026-11-20
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: BBIO · BridgeBio Pharma, Inc. (CIK 1743881)
- Kumar Neil director, officer (Chief Executive Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-18 | S sold | -4,490 | $76.9916 | 273,817 | D |
| Common Stock | 2026-11-18 | S sold | -30,490 | $77.8271 | 243,327 | D |
| Common Stock | 2026-11-18 | S sold | -1,277 | $76.9915 | 494,409 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. |
| Common Stock | 2026-11-18 | S sold | -8,723 | $77.8269 | 485,686 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. |
| Common Stock | 2026-11-19 | S sold | -8,500 | $78.3503 | 477,186 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. |
| Common Stock | 2026-11-19 | S sold | -1,500 | $79.293 | 475,686 | I By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. |
| Common Stock holding | 750,000 | I By NK 2026 GRAT | ||||
| Common Stock holding | 3,568,447 | I By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. |